| 000 | 01663 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515044053.0 | ||
| 264 | 0 | _c20061213 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 024 | 7 |
_a10.4049/jimmunol.177.9.6245 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLoeuillet, Corinne | |
| 245 | 0 | 0 |
_aMycobacterium tuberculosis subverts innate immunity to evade specific effectors. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cNov 2006 |
||
| 300 |
_a6245-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aApoptosis _ximmunology |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Nucleus _xchemistry |
| 650 | 0 | 4 | _aCell Wall |
| 650 | 0 | 4 |
_aFas Ligand Protein _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmune Tolerance |
| 650 | 0 | 4 | _aImmunity, Innate |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _ximmunology |
| 650 | 0 | 4 |
_aNF-kappa B _xagonists |
| 650 | 0 | 4 |
_aNod2 Signaling Adaptor Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPeptidoglycan _xpharmacology |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aToll-Like Receptor 2 _xagonists |
| 700 | 1 | _aMartinon, Fabio | |
| 700 | 1 | _aPerez, Cynthia | |
| 700 | 1 | _aMunoz, Miguel | |
| 700 | 1 | _aThome, Margot | |
| 700 | 1 | _aMeylan, Pascal R | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 177 _gno. 9 _gp. 6245-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.177.9.6245 _zAvailable from publisher's website |
| 999 |
_c16631701 _d16631701 |
||